Mehdi Hedayati
Mehdi Hedayati is an expert in Endocrinology at Shahid Beheshti University of Medical Sciences (Iran). As of October 2026, ScienceLeadR ranks Mehdi Hedayati in the top 1% of experts worldwide for Thyroid Neoplasms, Endocrine Gland Neoplasms and Glucose Metabolism Disorders. Mehdi Hedayati has authored 676 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 1,682 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Biochemistry - Genetics - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Mehdi Hedayati, PhD is a Professor of Biochemistry and Director of the Cellular and Molecular Endocrine Research Center at Shahid Beheshti University of Medical Sciences. He is currently a Visiting Scholar at Trent University, Ontario, Canada.
With more than two decades of research experience, Dr. Hedayati's work focuses on the biochemical, molecular, and genetic aspects of thyroid disorders, particularly thyroid cancer. His research integrates molecular endocrinology, biomarker discovery, and metabolomics to identify novel diagnostic and prognostic markers for thyroid diseases and to improve patient monitoring and follow-up strategies.
Dr. Hedayati is also an experienced laboratory methodologist with expertise in assay development, analytical validation, translational research, and omics-based approaches. He has authored more than 500 scientific publications, received over 14,000 citations, and has an H-index exceeding 55. His current research interests include metabolomics-driven precision diagnostics and systems-level approaches to endocrine diseases.
Organizations
Career arc: 2003 - 2026
Number : 676
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Early life stress caused glucose homeostasis impairment and anxiety-like behavior along with oxidative stress in adolescent male rat offspring: Protective effect of saffron extract. PMID 42842729 — insulin, homeostasis, stress, physiological, oxidative stress, amygdala, pancreas, adolescent, catalase, stress, psychological, plasma | PLoS One | 2026 | 0 |
| The Interplay Between Thyroid Cancer and Cardiovascular Disease: Shared Mechanisms, Treatment Implications, and Survivorship Perspectives. PMID 42768160 — cancer survivors, heart diseases, heart, cardiovascular diseases, neoplasms, thyroid gland, atrial fibrillation, hormones, survivorship, thyroid neoplasms, therapeutics | Cardiovasc Toxicol | 2026 | 0 |
| High Serum Monounsaturated Fatty Acids Levels May Increase Risk of Cardiovascular Disease: A Mendelian Randomization Study. PMID 42764857 — hypertension, fatty acids, monounsaturated, serum, cardiovascular diseases, random allocation, fatty acids | Iran J Med Sci | 2026 | 0 |
| A 25-year Experience in Quality Assurance: A Methodological Review of Laboratory Quality Control and Quality Assurance in the Tehran Lipid and Glucose Study (TLGS). PMID 42763642 — research design, quality control, creatinine, longitudinal studies, laboratories, cholesterol, triglycerides | Int J Endocrinol Metab | 2026 | 0 |
| Polyphenols intake and expression of insulin signaling genes in adipose tissue of obese adults: a cross-sectional study. PMID 42675145 — flavanones, genes, cross-sectional studies, insulin, stilbenes, obesity, flavonoids, tissues, polyphenols, adipose tissue, gene expression, anthocyanins | Sci Rep | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients NCT06096558 — quality of life, starch, blood, melatonin, peritoneal dialysis, sleep, lipoproteins, c-reactive protein, cardiovascular diseases, blood pressure, dietary supplements, tablets, cholesterol, risk factors, lipoprotein(a) | N/A | Not yet recruiting | 2023 |
LeadR Networks
Main global connection map